Top Markets
Coin of the day
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Rank in Stocks #30341
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Share Price
$0.13400411
Market Cap
$17.21M
Change (1 day)
-7.32%
Change (1 year)
-70.34%
Country
AU
Trade Argenica Therapeutics Ltd (AGN)

Category

Number of shares outstanding for Argenica Therapeutics Ltd (AGN)
Number of shares outstanding as of August 2026: 0
According to Argenica Therapeutics Ltd latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Argenica Therapeutics Ltd (AGN) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
483.58M -
AU
- -
CH
0.00 -
BE